News
The FDA has given the regulatory thumbs-up in the US of Reblozyl (luspatercept-aamt), the “first and only erythroid maturation agent” according to...
Gaza is at huge risk from the coronavirus pandemic due to years of living under a blockade from Israel which has crippled its infrastructure and...
Matt Hancock, the UK’s Health Secretary, has said that more patients with the COVID-19 coronavirus are need in clinical trials testing licensed drugs...
The European Commission has greenlighted Novo Nordisk’s Rybelsus (oral semaglutide) as an adjunct to diet and exercise to improve glycaemic control...
President Trump continues to push the drug hydroxychloroquine as a potential coronavirus treatment despite a lack of evidence for its effectiveness.
The European Commission has moved to authorise Ruxience, Pfizer’s biosimilar version of MabThera (rituximab). The decision marks the seventh...
COVID-19 coronavirus treatments dominate the news as the world looks for a vaccine. Johnson & Johnson announced that it has selected a candidate...
New Phase 3 data for the blockbuster immunotherapy Keytruda showed that the anti-PD-1 therapy met one of its main goals in the first-line treatment...
A British man has been accused of smuggling a fake coronavirus cure into the US and has been federally charged.
Sanofi and Regeneron have unveiled new Phase 3 data for their IL-4 and IL-13 inhibitor Dupixent (dupilumab), showing strong results in children aged...
Mission Statement
Pharmafile.com is a leading portal for the pharmaceutical industry, providing industry professionals with pharma news, pharma events, pharma service company listings and pharma jobs,
Site content is produced by our editorial team exclusively for Pharmafile.com and our industry newspaper Pharmafocus. Service company profiles and listings are taken from our pharmaceutical industry directory, Pharmafile, and presented in a unique Find and Compare format to ensure the most relevant matches
